119 related articles for article (PubMed ID: 24709085)
1. Authors' reply to the comments of Picillo et al. regarding "Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy".
Suzuki K; Numao A; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Jun; 20(6):682-3. PubMed ID: 24709085
[No Abstract] [Full Text] [Related]
2. Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Picillo M; Barone P; Erro R; Spina E; Pellecchia MT
Parkinsonism Relat Disord; 2014 Jun; 20(6):680-1. PubMed ID: 24630925
[No Abstract] [Full Text] [Related]
3. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
4. Low serum uric acid levels in progressive supranuclear palsy.
Oropesa-Ruiz JM; Huertas-Fernández I; Jesús S; Cáceres-Redondo MT; Vargas-Gonzalez L; Carrillo F; Carballo M; Gómez-Garre P; Mir P
Mov Disord; 2016 Mar; 31(3):402-5. PubMed ID: 26686202
[TBL] [Abstract][Full Text] [Related]
5. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomics study in a group of Parkinson's disease patients from northern India.
Nagesh Babu G; Gupta M; Paliwal VK; Singh S; Chatterji T; Roy R
Clin Chim Acta; 2018 May; 480():214-219. PubMed ID: 29474999
[TBL] [Abstract][Full Text] [Related]
7. Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.
Mori A; Ishikawa KI; Saiki S; Hatano T; Oji Y; Okuzumi A; Fujimaki M; Koinuma T; Ueno SI; Imamichi Y; Hattori N
PLoS One; 2019; 14(9):e0223113. PubMed ID: 31560709
[TBL] [Abstract][Full Text] [Related]
8. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
9. Serum adiponectin levels between patients with Parkinson's disease and those with PSP.
Kataoka H; Sugie K
Neurol Sci; 2020 May; 41(5):1125-1131. PubMed ID: 31897945
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
[TBL] [Abstract][Full Text] [Related]
11. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2017 Jul; 378():153-157. PubMed ID: 28566154
[TBL] [Abstract][Full Text] [Related]
13. The circulating level of leptin and blood pressure in patients with multiple system atrophy.
Ozawa T; Tokunaga J; Arakawa M; Ishikawa A; Takeuchi R; Yokoseki A; Sone H; Nishizawa M
J Neurol Sci; 2014 Dec; 347(1-2):349-51. PubMed ID: 25304054
[TBL] [Abstract][Full Text] [Related]
14. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T
Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484
[TBL] [Abstract][Full Text] [Related]
15. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.
Pellecchia MT; Pivonello R; Colao A; Barone P
Clin Med Res; 2006 Dec; 4(4):322-5. PubMed ID: 17210980
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
[TBL] [Abstract][Full Text] [Related]
18. Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies.
Constantinescu R; Andreasson U; Holmberg B; Zetterberg H
Acta Neurol Scand; 2013 Feb; 127(2):e8-12. PubMed ID: 22998191
[TBL] [Abstract][Full Text] [Related]
19. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
Wenning GK; Colosimo C
Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
